ArticleBMC neurology2026
Comprehensive diffusion tensor tractography of three dopaminergic pathways in advanced Parkinson's disease: a case report.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThis qualitative, exploratory case report presents comprehensive diffusion tensor tractography (DTT) analysis of all three major dopaminergic pathways in advanced Parkinson’s disease (PD), which is rarely reported. We present a case demonstrating structural alterations across mesocortical, mesolimbic, and nigrostriatal pathways in a patient with severe motor and non-motor symptoms, highlighting DTT’s educational and clinical visualization value. CASE PRESENTATION: A 77-year-old female with advanced PD presented with a complex symptom profile including severe cognitive impairment (MMSE not assessable), major depression (predating motor symptoms by 7 years), severe dysphagia with silent aspiration (PAS 8), bilateral motor weakness (MMT P- to P+), and wheelchair dependence. DTT analysis revealed marked architectural differences compared to an age-matched control subject. The mesocortical tract showed notably reduced fiber density and thinning, particularly in prefrontal cortex projections. The mesolimbic tract demonstrated diminished volume with altered trajectory patterns, especially affecting ventral tegmental area connections. The nigrostriatal tract exhibited the most pronounced degeneration with markedly reduced fiber density and widespread disruption of tract integrity.
conclusionsWhile qualitative in nature and limited by single-case design and comparison with a single age-matched control subject acquired on a different MRI system, this case illustrates comprehensive structural deterioration across three dopaminergic pathways in advanced PD, with pathway-specific structural features observed alongside the patient’s complex clinical presentation. This detailed visualization demonstrates DTT’s potential utility as a clinical tool for understanding both motor and non-motor manifestations in advanced PD. The findings highlight the educational value of comprehensive dopaminergic pathway assessment and suggest directions for future controlled studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.